GB0220885D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0220885D0
GB0220885D0 GBGB0220885.8A GB0220885A GB0220885D0 GB 0220885 D0 GB0220885 D0 GB 0220885D0 GB 0220885 A GB0220885 A GB 0220885A GB 0220885 D0 GB0220885 D0 GB 0220885D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0220885.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0220885.8A priority Critical patent/GB0220885D0/en
Publication of GB0220885D0 publication Critical patent/GB0220885D0/en
Priority to BR0314081-4A priority patent/BR0314081A/pt
Priority to JP2004535458A priority patent/JP2006500401A/ja
Priority to PCT/EP2003/009972 priority patent/WO2004024165A1/en
Priority to CNB038213338A priority patent/CN1327844C/zh
Priority to US10/526,282 priority patent/US20060234985A1/en
Priority to AU2003270154A priority patent/AU2003270154A1/en
Priority to CA002497182A priority patent/CA2497182A1/en
Priority to HK06100805.9A priority patent/HK1080734B/xx
Priority to EP03750497A priority patent/EP1539186A1/en
Priority to US12/431,347 priority patent/US20090209493A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0220885.8A 2002-09-09 2002-09-09 Organic compounds Ceased GB0220885D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0220885.8A GB0220885D0 (en) 2002-09-09 2002-09-09 Organic compounds
EP03750497A EP1539186A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
CNB038213338A CN1327844C (zh) 2002-09-09 2003-09-08 包含双膦酸类化合物和hmg－coa还原酶抑制剂的组合疗法
JP2004535458A JP2006500401A (ja) 2002-09-09 2003-09-08 ビスホスホネートおよびｈｍｇ−ｃｏａレダクターゼインヒビターを含む組合せ治療
PCT/EP2003/009972 WO2004024165A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
BR0314081-4A BR0314081A (pt) 2002-09-09 2003-09-08 Terapia de combinação compreendendo um bisfosfonato e um inibidor de hmg-coa redutase
US10/526,282 US20060234985A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
AU2003270154A AU2003270154A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
CA002497182A CA2497182A1 (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
HK06100805.9A HK1080734B (en) 2002-09-09 2003-09-08 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
US12/431,347 US20090209493A1 (en) 2002-09-09 2009-04-28 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0220885.8A GB0220885D0 (en) 2002-09-09 2002-09-09 Organic compounds

Publications (1)

Publication Number Publication Date
GB0220885D0 true GB0220885D0 (en) 2002-10-16

Family

ID=9943733

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0220885.8A Ceased GB0220885D0 (en) 2002-09-09 2002-09-09 Organic compounds

Country Status (9)

Country Link
US (2) US20060234985A1 (enExample)
EP (1) EP1539186A1 (enExample)
JP (1) JP2006500401A (enExample)
CN (1) CN1327844C (enExample)
AU (1) AU2003270154A1 (enExample)
BR (1) BR0314081A (enExample)
CA (1) CA2497182A1 (enExample)
GB (1) GB0220885D0 (enExample)
WO (1) WO2004024165A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327742D0 (en) * 2003-11-28 2003-12-31 Isis Innovation Novel uses of known drugs
WO2008128056A1 (en) 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
WO2006039721A2 (en) 2004-10-08 2006-04-13 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
EP2001486A4 (en) 2006-03-17 2010-12-29 Univ Illinois BIPHOSPHONATE COMPOUNDS AND CORRESPONDING METHODS
FR2903312B1 (fr) 2006-07-05 2008-09-26 Univ Aix Marseille Ii Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament
AU2008353145B2 (en) * 2008-01-03 2013-09-12 Universite D' Aix-Marseille Bitherapy and tritherapy used for treating an HIV-positive patient
ES2339524B1 (es) * 2008-08-28 2011-03-22 Proyecto De Biomedicina Cima, S.L. Nuevo biomarcador como diana terapeutica en cancer de pulmon.
KR101813728B1 (ko) 2009-07-31 2017-12-29 그뤼넨탈 게엠베하 결정화 방법 및 생체이용률
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
CA2825424A1 (en) * 2010-02-08 2011-08-11 Board Of Regents Of The University Of Nebraska Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
WO2012071517A2 (en) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
US9308190B2 (en) 2011-06-06 2016-04-12 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin
WO2017208070A1 (en) 2016-05-31 2017-12-07 Grünenthal GmbH Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080779A (en) * 1996-12-13 2000-06-27 Osteoscreen, Inc. Compositions and methods for stimulating bone growth
US20010025028A1 (en) * 1998-03-13 2001-09-27 Merck & Co., Inc. Methods of inhibiting bone resorption
JP2002506030A (ja) * 1998-03-13 2002-02-26 メルク エンド カムパニー インコーポレーテッド 骨再吸収の阻害方法
ID27933A (id) * 1998-05-12 2001-05-03 Warner Lambert Co Gabungan protein farnesiltransferase dan inhibitor hmg-coa reduktase serta penggunaannya untuk mengobati kanker
US6620821B2 (en) * 2000-06-15 2003-09-16 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
US20020028826A1 (en) * 2000-06-15 2002-03-07 Robl Jeffrey A. HMG-CoA reductase inhibitors and method
WO2002028270A2 (en) * 2000-10-06 2002-04-11 Probiochem, Llc The treatment of cancer utilizing a cox-2 inhibitor and a hmg-coa reductase inhibitor

Also Published As

Publication number Publication date
EP1539186A1 (en) 2005-06-15
CN1327844C (zh) 2007-07-25
US20060234985A1 (en) 2006-10-19
US20090209493A1 (en) 2009-08-20
JP2006500401A (ja) 2006-01-05
WO2004024165A1 (en) 2004-03-25
HK1080734A1 (en) 2006-05-04
CN1681515A (zh) 2005-10-12
CA2497182A1 (en) 2004-03-25
BR0314081A (pt) 2005-07-05
AU2003270154A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
GB0203276D0 (en) Organic compounds
GB0202873D0 (en) Organic compounds
GB0209265D0 (en) Organic compounds
GB0205281D0 (en) Organic compounds
GB0200429D0 (en) Organic compounds
EG23462A (en) Organic compounds
GB0209481D0 (en) Organic compounds
GB0203061D0 (en) Organic compounds
GB0202874D0 (en) Organic compounds
GB0204756D0 (en) Organic compounds
GB0211261D0 (en) Organic compounds
GB0210535D0 (en) Organic compounds
GB0209257D0 (en) Organic compounds
GB0202381D0 (en) Organic compounds
GB0205537D0 (en) Organic compounds
GB0207500D0 (en) Organic compounds
GB0209887D0 (en) Organic compounds
GB0204763D0 (en) Organic compounds
GB0209885D0 (en) Organic compounds
GB0205023D0 (en) Organic compounds
GB0206694D0 (en) Organic compounds
GB0201913D0 (en) Organic compounds
GB0207499D0 (en) Organic compounds
GB0207726D0 (en) Organic compounds
GB0207731D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)